Skip to main content

Table 6 HCVcAg at baseline, the 12th week, and the 24th week regarding treatment response

From: Hepatitis C core antigen: a simple predictive marker for treatment response to the new direct-acting antiviral drugs in chronic HCV Egyptian patients

Response of cases (No. = 280) HCVcAg (Peiu/ml)
Baseline At the 12th week At the 24th week
Detectable Undetectable Detectable Undetectable
Responder/SVR (No. = 260) 2.7 ± 2.1 0 0.0% 260 100% 0 0.0% 260 100%
Non-responder (No. = 10) 1.7 10 100% 0 0.0% 10 100% 0 0.0%
Relapse (No. = 10) 3.5 0 0.0% 10 100% 10 100% 0 0.0%